Ridgeback Biotherapeutics


We focus on pediatric orphan and infectious diseases that have limited available treatment options or none at all.  Millions of people worldwide suffer every year from known and emerging infectious diseases that have few therapeutics options – primarily because these patients are in the developing world.  At the other end of the spectrum, small populations of children suffer from a little known or possibly undefined disease with few stakeholders interested or capable of investment.  These are the diseases that we care about.  We are interested in partnering and sponsoring research with academic centers and inventors who share our same goals and values.  For more information, please contact: info@ridgebackbio.com.

Expanded Access Policy